The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
ADAGENE | ADR | 005329107 | 382,800 | 264,000 | SH | SOLE | 264,000 | 0 | 0 | |||
ALIGNMENT HEALTHCARE | COM | 01625V104 | 387,917,534 | 60,993,323 | SH | SOLE | 60,993,323 | 0 | 0 | |||
ALKAMI | COM | 01644J108 | 237,119,344 | 18,729,806 | SH | SOLE | 18,729,806 | 0 | 0 | |||
ARCO PLATFORM LIMITED | CL A | G04553106 | 44,972,891 | 4,103,366 | SH | SOLE | 4,103,366 | 0 | 0 | |||
BLEND LABS | CL A | 09352U108 | 19,059,737 | 19,132,440 | SH | SOLE | 19,132,440 | 0 | 0 | |||
BUZZFEED | CL A | 12430A102 | 8,884,627 | 7,862,502 | SH | SOLE | 7,862,502 | 0 | 0 | |||
CENTESSA PHARMACEUTICALS | SPONSORED ADS | 152309100 | 37,274,999 | 9,681,818 | SH | SOLE | 9,681,818 | 0 | 0 | |||
CHINA INDEX HOLDINGS | SPNSRD ADS | 16954W101 | 9,544,759 | 10,122,769 | SH | SOLE | 10,122,769 | 0 | 0 | |||
CLEAR SECURE | CL A | 18467V109 | 127,215,510 | 4,861,120 | SH | SOLE | 4,861,120 | 0 | 0 | |||
DLOCAL | CL A | G29018101 | 1,001,520,363 | 61,746,015 | SH | SOLE | 61,746,015 | 0 | 0 | |||
DUOLINGO | CL A | 26603R106 | 166,016,681 | 1,164,294 | SH | SOLE | 1,164,294 | 0 | 0 | |||
ENGAGESMART | COM | 29283F103 | 1,737,727,145 | 90,271,540 | SH | SOLE | 90,271,540 | 0 | 0 | |||
EUROPEAN WAX CENTER | CL A | 29882P106 | 249,099,348 | 13,110,492 | SH | SOLE | 13,110,492 | 0 | 0 | |||
FUTU | SPON ADS CL A | 36118L106 | 57,633,556 | 1,111,544 | SH | SOLE | 1,111,544 | 0 | 0 | |||
GINKGO BIOWORKS | CL A | 37611X100 | 42,985,462 | 32,319,896 | SH | SOLE | 32,319,896 | 0 | 0 | |||
GROVE COLLABORATIVE | CL A | 39957D102 | 2,049,884 | 4,680,100 | SH | SOLE | 4,680,100 | 0 | 0 | |||
HIRERIGHT | COM | 433537107 | 340,686,018 | 32,109,898 | SH | SOLE | 32,109,898 | 0 | 0 | |||
HUTCHMED | SPONSORED ADS | 44842L103 | 52,080,000 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | |||
IMMUNOCORE | ADS | 45258D105 | 46,968,000 | 950,000 | SH | SOLE | 950,000 | 0 | 0 | |||
KARUNA THERAPEUTICS | COM | 48576A100 | 130,082,939 | 716,158 | SH | SOLE | 716,158 | 0 | 0 | |||
MOBILEYE | CL A | 60741F104 | 206,047,629 | 4,761,905 | SH | SOLE | 4,761,905 | 0 | 0 | |||
OAK STREET HEALTH | COM | 67181A107 | 2,374,351,493 | 61,384,475 | SH | SOLE | 61,384,475 | 0 | 0 | |||
OPENDOOR | COM | 683712103 | 11,125,873 | 6,321,519 | SH | SOLE | 6,321,519 | 0 | 0 | |||
PHARVARIS | ORD | N69605108 | 19,494,349 | 2,420,155 | SH | SOLE | 2,420,155 | 0 | 0 | |||
RISKIFIED | CL A | M8216R109 | 30,032,989 | 5,324,998 | SH | SOLE | 5,324,998 | 0 | 0 | |||
ROYALTY PHARMA | SHS CLASS A | G7709Q104 | 54,045,000 | 1,500,000 | SH | SOLE | 1,500,000 | 0 | 0 | |||
SAMSARA | CL A | 79589L106 | 181,956,834 | 9,227,020 | SH | SOLE | 9,227,020 | 0 | 0 | |||
SQUARESPACE | CL A | 85225A107 | 710,411,289 | 22,361,073 | SH | SOLE | 22,361,073 | 0 | 0 | |||
THIRD HARMONIC BIO | COM | 88427A107 | 12,190,099 | 2,958,762 | SH | SOLE | 2,958,762 | 0 | 0 | |||
WISH | CL A | 21077C107 | 8,153,003 | 18,288,478 | SH | SOLE | 18,288,478 | 0 | 0 | |||
XP, INC | CL A | G98239109 | 300,521,491 | 25,317,733 | SH | SOLE | 25,317,733 | 0 | 0 |